📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Opexa Therapeutics

1.1 - Company Overview

Opexa Therapeutics Logo

Opexa Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of patient-specific immunotherapies for the treatment of multiple sclerosis; its lead candidate, Tcelna, is a personalized T-cell immunotherapy in Phase IIb clinical development (the Abili-T trial).

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Opexa Therapeutics

Maverick Therapeutics Logo

Maverick Therapeutics

HQ: United States Website
  • Description: Provider of T cell immunotherapies for solid tumor cancers, developing breakthrough treatments with improved safety and efficacy via COBRA, the most advanced bispecific T cell engaging platform in its class designed to safely target solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Maverick Therapeutics company profile →
Syntimmune Logo

Syntimmune

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology drug candidates for a wide range of autoimmune diseases, advancing differentiated therapies based on expertise in neonatal Fc receptor (FcRn) biology and its role in the pathogenesis of IgG-mediated conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Syntimmune company profile →
Outlook Therapeutics Logo

Outlook Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical development focused on ophthalmic formulations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Outlook Therapeutics company profile →
Selexis Logo

Selexis

HQ: Switzerland Website
  • Description: Provider of proprietary technology and highly specialized expertise for mammalian (suspension-adapted CHO-K1) cell line generation, helping translate scientific innovation into life-saving medicines for patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Selexis company profile →
Senesco Technologies Logo

Senesco Technologies

HQ: United States Website
  • Description: Provider of biotech research and development focused on cancer therapeutics and plant gene research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Senesco Technologies company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Opexa Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Opexa Therapeutics

2.2 - Growth funds investing in similar companies to Opexa Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Opexa Therapeutics

4.2 - Public trading comparable groups for Opexa Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Opexa Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Opexa Therapeutics

What does Opexa Therapeutics do?

Opexa Therapeutics is a provider of patient-specific immunotherapies for the treatment of multiple sclerosis; its lead candidate, Tcelna, is a personalized T-cell immunotherapy in Phase IIb clinical development (the Abili-T trial).

Who are Opexa Therapeutics's competitors?

Opexa Therapeutics's competitors and similar companies include Maverick Therapeutics, Syntimmune, Outlook Therapeutics, Selexis, and Senesco Technologies.

Where is Opexa Therapeutics headquartered?

Opexa Therapeutics is headquartered in United States.

How many employees does Opexa Therapeutics have?

Opexa Therapeutics has 1,000 employees 🔒.

When was Opexa Therapeutics founded?

Opexa Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Opexa Therapeutics in?

Opexa Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Opexa Therapeutics

Who are the top strategic acquirers in Opexa Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Opexa Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Opexa Therapeutics?

Top strategic M&A buyers groups and sectors for Opexa Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Opexa Therapeutics's sector and industry vertical

Which are the top PE firms investing in Opexa Therapeutics's sector and industry vertical?

Top PE firms investing in Opexa Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Opexa Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Opexa Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Opexa Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Opexa Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Opexa Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Opexa Therapeutics?

The key public trading comparables and valuation benchmarks for Opexa Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Opexa Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Opexa Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Opexa Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Opexa Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Opexa Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Opexa Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Opexa Therapeutics